[The follow-up of PSA tests for the early detection of prostate cancer. The responsibility of the physician to explain treatment methods which are not covered by public health insurance plans].
Cramer
R
R
cramer@soh.ce
Dahm
F-J
FJ
D005858:Germany; D019983:Guideline Adherence / Q000941:ethics / Q000331:legislation & jurisprudence; D006801:Humans; D019458:Insurance Coverage / Q000941:ethics* / Q000331:legislation & jurisprudence*; D008297:Male; D009313:National Health Programs / Q000941:ethics / Q000331:legislation & jurisprudence*; D010817:Physician-Patient Relations / Q000941:ethics*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000628:therapy*; D018570:Risk Assessment / Q000941:ethics / Q000331:legislation & jurisprudence; D012307:Risk Factors
D017430:Prostate-Specific Antigen